LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein.
Saved in:
| Title: | LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. |
|---|---|
| Authors: | Shilts J; Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, United Kingdom.; Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York, United Kingdom., Crozier TWM; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Teixeira-Silva A; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Gabaev I; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Gerber PP; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Greenwood EJD; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Watson SJ; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Ortmann BM; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Gawden-Bone CM; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Pauzaite T; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Hoffmann M; Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.; Faculty of Biology and Psychology, Georg-August University Göttingen, Göttingen, Germany., Nathan JA; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Pöhlmann S; Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.; Faculty of Biology and Psychology, Georg-August University Göttingen, Göttingen, Germany., Matheson NJ; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom., Lehner PJ; Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Wright GJ; Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, United Kingdom.; Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York, United Kingdom. |
| Source: | PLoS biology [PLoS Biol] 2023 Feb 03; Vol. 21 (2), pp. e3001959. Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-7885 |
|---|---|
| DOI: | 10.1371/journal.pbio.3001959 |
